Warning letter
Galveston Medical Supplies Inc.: warning letter of Apr 12, 2000
FDA warning letter UCM078260 · Dallas District Office
Key facts
| Reference number | UCM078260 |
|---|---|
| Company | Galveston Medical Supplies Inc. |
| Subject | CGMP/Liquid Oxygen/Adulterated |
| Issue date | Apr 12, 2000 |
| Posted date | Apr 12, 2000 |
| Issuing office | Dallas District Office |
| Product type | Drugs |
| CFR sections cited | 211.165(a), 21, 211, 211.188, 211.192, 211.22(a), 211.130(b), 211.186(b) |
| Country | 3 |
| Inspection city | Galveston |
| Inspection ZIP | 77550-2101 |
| Inspection start date | Feb 29, 2000 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: